News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
The current state of radiotherapeutics is “the isotope wars”, according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback